|
Video: What is a Stock Split?
|
|
Graphite Bio develops therapies to cure a range of serious and life-threatening diseases. Co.'s gene editing platform is designed to correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Co.'s product candidate nulabeglogene autogedtemcel is designed to correct the genetic mutation responsible for sickle cell disease. Co.'s gene replacement approach is designed to allow it to replace dysfunctional genes with a normal copy of an entire gene at its normal location in the chromosome. Co. has two gene replacement programs, one for beta-thalassemia and another for X-linked severe combined immunodeficiency syndrome. According to our LENZ split history records, Lenz Therapeutics Inc New has had 1 split. | |
|
Lenz Therapeutics Inc New (LENZ) has 1 split in our LENZ split history database. The split for LENZ took place on March 22, 2024. This was a 1 for 7 reverse split, meaning for each 7 shares of LENZ owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.
When a company such as Lenz Therapeutics Inc New conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the LENZ split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lenz Therapeutics Inc New shares, starting with a $10,000 purchase of LENZ, presented on a split-history-adjusted basis factoring in the complete LENZ split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
06/25/2021 |
|
End date: |
04/29/2024 |
|
Start price/share: |
$129.50 |
|
End price/share: |
$16.50 |
|
Starting shares: |
77.22 |
|
Ending shares: |
146.00 |
|
Dividends reinvested/share: |
$14.42 |
|
Total return: |
-75.91% |
|
Average Annual Total Return: |
-39.35% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,408.86 |
|
Years: |
2.85 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/25/2021 |
|
End date: |
04/29/2024 |
|
Start price/share: |
$129.50 |
|
End price/share: |
$16.50 |
|
Dividends collected/share: |
$14.42 |
|
Total return: |
-76.12% |
|
Average Annual Total Return: |
-39.54% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,387.44 |
|
Years: |
2.85 |
|
|
|
Date |
Ratio |
03/22/2024 | 1 for 7 |
|
|